An Elderly Case of Paraneoplastic Anti-NMDA Receptor Encephalitis Associated with Small-cell Lung Cancer Expressing NR1 Subunits

Intern Med. 2020 Sep 15;59(18):2307-2309. doi: 10.2169/internalmedicine.4860-20. Epub 2020 Jun 2.

Abstract

A 61-year-old Japanese man presented with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis. NR1 antibodies were detected in his cerebrospinal fluid. Chest computed tomography revealed lung tumor. The patient was diagnosed with paraneoplastic anti-NMDAR encephalitis associated with lung cancer and treated with two cycles of intravenous high-dose methylprednisolone and one cycle of intravenous immunoglobulin. However, he died one year later without improvement. An autopsy confirmed small-cell lung cancer (SCLC). Immunohistochemistry revealed the expression of NR1 subunits in the tumor cells, suggesting that SCLC may trigger NR1 autoimmunity though the expression of NR1 subunits as onconeural antigens, expanding the phenotypic spectrum of paraneoplastic neurological syndrome associated with SCLC.

Keywords: NMDAR; SCLC; anti-N-methyl-D-aspartate receptor; encephalitis; paraneoplastic syndrome; small cell lung cancer.

Publication types

  • Case Reports

MeSH terms

  • Anti-N-Methyl-D-Aspartate Receptor Encephalitis / complications*
  • Anti-N-Methyl-D-Aspartate Receptor Encephalitis / diagnosis
  • Antibodies / therapeutic use
  • Autoantibodies
  • Humans
  • Immunoglobulins / therapeutic use
  • Immunoglobulins, Intravenous / therapeutic use
  • Immunohistochemistry
  • Lung Neoplasms / complications*
  • Lung Neoplasms / drug therapy
  • Male
  • Methylprednisolone / therapeutic use
  • Middle Aged
  • Receptors, N-Methyl-D-Aspartate / immunology
  • Small Cell Lung Carcinoma / complications*
  • Small Cell Lung Carcinoma / drug therapy

Substances

  • Antibodies
  • Autoantibodies
  • Immunoglobulins
  • Immunoglobulins, Intravenous
  • NR1 NMDA receptor
  • Receptors, N-Methyl-D-Aspartate
  • Methylprednisolone